PTPRC and neoplasm: Immunofluorescence (IF) staining of CT2A tumor tissues revealed that, compared with vehicle treatment, cinobufagin treatment significantly increased the infiltration of CD45+ immune cells, with a particularly notable increase in CD4+ T cells and CD8+ T cells.